145 related articles for article (PubMed ID: 30048768)
21. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
[TBL] [Abstract][Full Text] [Related]
22. Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome.
de Martino M; Galli L; Azzari C; Zammarchi E; Vierucci A
Vox Sang; 1994; 67(3):317-9. PubMed ID: 7863634
[No Abstract] [Full Text] [Related]
23. Prolonged survival after splenectomy in Wiskott-Aldrich syndrome: a case report.
Syrigos KN; Makrilia N; Neidhart J; Moutsos M; Tsimpoukis S; Kiagia M; Saif MW
Ital J Pediatr; 2011 Sep; 37():42. PubMed ID: 21906397
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott-Aldrich syndrome.
Khoreva A; Abramova I; Deripapa E; Rodina Y; Roppelt A; Pershin D; Larin S; Voronin K; Maschan A; Novichkova G; Shcherbina A
Br J Haematol; 2021 Jan; 192(2):366-374. PubMed ID: 33131064
[TBL] [Abstract][Full Text] [Related]
25. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous manifestations in patients with Wiskott-Aldrich syndrome submitted to haematopoietic stem cell transplantation.
Loyola Presa JG; de Carvalho VO; Morrisey LR; Bonfim CM; Abagge KT; Vasselai A; Marinoni LP
Arch Dis Child; 2013 Apr; 98(4):304-7. PubMed ID: 23343520
[TBL] [Abstract][Full Text] [Related]
27. One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years.
Elfeky RA; Furtado-Silva JM; Chiesa R; Rao K; Amrolia P; Lucchini G; Gilmour K; Adams S; Bibi S; Worth A; Thrasher AJ; Qasim W; Veys P
J Allergy Clin Immunol; 2018 Nov; 142(5):1654-1656.e7. PubMed ID: 30055182
[No Abstract] [Full Text] [Related]
28. Clinical Features and Outcomes of 23 Patients with Wiskott-Aldrich Syndrome: A Single-Center Experience.
Haskoloğlu Ş; Öztürk A; Öztürk G; Kostel Bal S; İslamoğlu C; Baskın K; Ceylaner S; Tufan Satıroğlu L; Doğu F; İkincioğulları A
Turk J Haematol; 2020 Nov; 37(4):271-281. PubMed ID: 32812413
[TBL] [Abstract][Full Text] [Related]
29. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome.
Mathew P; Conley ME
Pediatr Allergy Immunol; 1995 May; 6(2):91-4. PubMed ID: 7581726
[TBL] [Abstract][Full Text] [Related]
30. Malignant lymphoma of the jejunum in a patient with Wiskott-Aldrich syndrome. Surgical treatment.
Faraci RP; Hoffstrand HJ; Witebsky FG; Blaese RM; Beazley RM
Arch Surg; 1975 Feb; 110(2):218-20. PubMed ID: 1115623
[TBL] [Abstract][Full Text] [Related]
31. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
[TBL] [Abstract][Full Text] [Related]
32. Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care.
Agarwal N; Citla Sridhar D; Malay S; Patil N; Shekar A; Ahuja S; Dalal J
Sci Rep; 2021 Feb; 11(1):4654. PubMed ID: 33633315
[TBL] [Abstract][Full Text] [Related]
33. Eltrombopag use in a patient with Wiskott-Aldrich syndrome.
Gabelli M; Marzollo A; Notarangelo LD; Basso G; Putti MC
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643468
[TBL] [Abstract][Full Text] [Related]
34. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.
Dupuis-Girod S; Medioni J; Haddad E; Quartier P; Cavazzana-Calvo M; Le Deist F; de Saint Basile G; Delaunay J; Schwarz K; Casanova JL; Blanche S; Fischer A
Pediatrics; 2003 May; 111(5 Pt 1):e622-7. PubMed ID: 12728121
[TBL] [Abstract][Full Text] [Related]
35. Splenectomy in the Wiskott-Aldrich syndrome.
Nathan DG
N Engl J Med; 1980 Apr; 302(16):916-7. PubMed ID: 6767188
[No Abstract] [Full Text] [Related]
36. Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura.
Toyoda H; Azuma E; Kawasaki Y; Iwasa T; Ohashi H; Otsuki S; Iwamoto S; Hirayama M; Itoh-Habe N; Wada H; Kondo M; Keida Y; Ito T; Komada Y
J Allergy Clin Immunol; 2013 Jul; 132(1):226-7. PubMed ID: 23498591
[No Abstract] [Full Text] [Related]
37. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome.
Corash L; Shafer B; Blaese RM
Blood; 1985 Jun; 65(6):1439-43. PubMed ID: 3995178
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
39. Wiskott Aldrich syndrome: a treatable immune disorder. A review.
Millikan LE
Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682
[No Abstract] [Full Text] [Related]
40. Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for Wiskott-Aldrich syndrome.
Yasuda Y; Yabe H; Inoue H; Shimizu T; Yabe M; Yogo Y; Kato S
Pediatr Int; 2008 Apr; 50(2):238-40. PubMed ID: 18353068
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
